Lab901, Seegene Strike Distribution, Co-marketing Agreement | GenomeWeb
NEW YORK (GenomeWeb News) – The Korean PCR diagnostics company Seegene will distribute Lab901’s ScreenTape system in the Korean market, Lab901 said Monday.
 
Under the agreement, the two companies will co-market both the ScreenTape system and Seegene’s Seeplex products in the global market, the company said.
 
The Seeplex products are multiplex PCR-based tests designed to detect multiple pathogens, including sexually transmitted diseases, respiratory viruses, sepsis, human papillomavirus, and pneumonia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.